Stay updated on Apremilast in Nummular Eczema Clinical Trial

Sign up to get notified when there's something new on the Apremilast in Nummular Eczema Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Apremilast in Nummular Eczema Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A dedicated Locations section was added, listing Bavaria as a study site, and the page revision updated to v3.3.3. The older grouping 'Bavaria Locations' was removed along with the HHS Vulnerability Disclosure link.
    Difference
    0.2%
    Check dated 2025-12-23T21:56:35.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now displays a new revision header 'Revision: v3.3.2' replacing the previous 'Revision: v3.2.0'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:12:40.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The government funding status notice has been removed from the page. The notice previously informed users about potential delays in updates and responses due to funding lapses.
    Difference
    0.4%
    Check dated 2025-11-18T06:59:35.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The screenshots show only minor visual/layout adjustments; the core study details appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:01:46.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page is updated to v3.2.0 and adds a government operating-status notice, replacing the previous v3.1.0 reference.
    Difference
    4%
    Check dated 2025-10-06T05:27:28.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Page now shows revision to v3.1.0 and removes several drug-safety-related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a shift away from those topics while adding a new version.
    Difference
    0.4%
    Check dated 2025-09-29T03:04:18.000Z thumbnail image

Stay in the know with updates to Apremilast in Nummular Eczema Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Apremilast in Nummular Eczema Clinical Trial page.